Department of Pediatrics, Columbia University, New York 10032, USA.
J Infect Dis. 2013 May 15;207(10):1491-7. doi: 10.1093/infdis/jit047. Epub 2013 Feb 19.
Bacterial vaginosis is a highly prevalent and poorly understood polymicrobial disorder of the vaginal microbiota, with significant adverse sequelae. Gardnerella vaginalis predominates in bacterial vaginosis. Biofilms of G. vaginalis are present in human infections and are implicated in persistent disease, treatment failure, and transmission. Here we demonstrate that G. vaginalis biofilms contain extracellular DNA, which is essential to their structural integrity. Enzymatic disruption of this DNA specifically inhibits biofilms, acting on both newly forming and established biofilms. DNase liberates bacteria from the biofilm to supernatant fractions and potentiates the activity of metronidazole, an antimicrobial agent used in the treatment of bacterial vaginosis. Using a new murine vaginal colonization model for G. vaginalis, we demonstrate >10-fold inhibition of G. vaginalis colonization by DNase. We conclude that DNase merits investigation as a potential nonantibiotic adjunct to existing bacterial vaginosis therapies in order to decrease the risk of chronic infection, recurrence, and associated morbidities.
细菌性阴道病是一种高度流行且尚未被充分认识的阴道微生物群多微生物紊乱,会导致严重的不良后果。阴道加德纳菌在细菌性阴道病中占优势。人类感染中存在阴道加德纳菌的生物膜,并且与持续性疾病、治疗失败和传播有关。在这里,我们证明了阴道加德纳菌生物膜中含有对其结构完整性至关重要的细胞外 DNA。对这种 DNA 的酶促破坏专门抑制生物膜,对新形成的和已建立的生物膜均起作用。DNase 将细菌从生物膜释放到上清液中,并增强甲硝唑(一种用于治疗细菌性阴道病的抗菌药物)的活性。使用一种新的阴道加德纳菌小鼠定植模型,我们证明 DNase 对阴道加德纳菌定植的抑制作用超过 10 倍。我们得出结论,DNase 值得作为一种潜在的非抗生素辅助治疗方法进行研究,以降低慢性感染、复发和相关发病率的风险。